Docosatetraenoic acid is one of these Omega-6 Polyunsaturated Fatty Acids:
– Linoleic Acid
– Gamma Linolenic Acid
– Eicosadienoic Acid
– Dihomogamma Linolenic Acid
– Arachidonic Acid
– Docosatetraenoic Acid
Docosatetraenoic acid is also known as Adrenic acid / Adrenate.
Fatty acids belong to one of three types or families: saturated, monounsaturated and polyunsaturated. These names describe the structure of the fatty acid in terms of whether it is fully loaded with hydrogen.
Docosatetraenoic acid is a member of the class of compounds known as very long-chain fatty acids.
When omega-6 dietary fatty acids are consumed in abundance, there is an accumulation of desaturation and elongation intermediates. Diets high in fat and simple sugars contribute to obesity and to the accumulation of docosatetraenoic acid.
Increases in polyunsaturated fatty acids can lead to chronic inflammatory diseases such as:
– nonalcoholic fatty liver disease (NAFLD),
– cardiovascular disease,
– type 2 diabetes,
– obesity, inflammatory bowel disease (IBD),
– rheumatoid arthritis,
– and Alzheimer’s disease (AD).
Potential Responses: Weight control / Glycemic control
Metabolic Association: Increase in adipose tissue
– Health Implications of High Dietary Omega-6 Polyunsaturated Fatty Acids [L]
– Significance of long chain polyunsaturated fatty acids in human health [L]
– Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease. [L]
– Plasma fatty acid profile as biomarker of coronary artery disease: a pilot study using fourth generation artificial neural networks. [L]
– Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study [L]
The information on healthmatters.io is NOT intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice.